Rahber Thariani

Tumor Marker Usage and Medical Care Costs Among Older Early-Stage Breast Cancer Survivors

Scott D. Ramsey, N. Lynn Henry, Julie R. Gralow et al. · Journal of Clinical Oncology · 2014 · 55 citations

Medicine, Biostatistics, Oncology +14

Value-of-Information Analysis within a Stakeholder-Driven Research Prioritization Process in a US Setting: An Application in Cancer Genomics

Josh J. Carlson, Rahber Thariani, Josh Roth et al. · Medical Decision Making · 2013 · 43 citations

Public Health, Biostatistics, Oncology +17

Prioritization in Comparative Effectiveness Research

Rahber Thariani, William B. Wong, Josh J. Carlson et al. · Medical Care · 2012 · 24 citations · Full text

Pharmacy, Pharmacoeconomics, Comparative Effectiveness Research +8

Paying for personalized care: Cancer biomarkers and comparative effectiveness

Rahber Thariani, David L. Veenstra, Josh J. Carlson et al. · Molecular Oncology · 2012 · 23 citations

Medicine, Oncology, Pharmacoeconomics +13

Cost–Effectiveness of Pharmacogenetic-Guided Dosing of Phenprocoumon in Atrial Fibrillation

Talitha I. Verhoef, Ken Redekop, David L. Veenstra et al. · Pharmacogenomics · 2013 · 21 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacology +17